Meningitis - Clinical trials 

  • Clinical trials

Clinical trials for Meningitis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Meningitis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Meningitis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Meningitis
Title Recruitment status Location
Can we Reduce the Number of Vaccine Injections for Children? Recruiting United Kingdom
A Phase 2b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered with or without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules - ND Not Recruiting United Kingdom
An Alternative Booster Vaccine Against Meningitis and Ear Infections Not recruiting United Kingdom
Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis Not recruiting United Kingdom
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12 Not recruiting United Kingdom
Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults Not recruiting United Kingdom
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants Not recruiting United Kingdom
Understanding the Immune Response to Two Different Meningitis Vaccines Not recruiting United Kingdom
A Phase IV, randomised study to evaluate the immune response of UK infants receiving DTaP/Hib/IPV, meningococcal C conjugate and pneumococcal conjugate vaccines, antibody persistence and responses to booster doses in the second year of life. (code: Sched2) - Sched2 Not Recruiting United Kingdom
A phase 2, open-label study of the safety, tolerability and immunogenicity of a Novartis meningococcal B vaccine when administered at a 0, 2, 6 month schedule and of a single dose of Novartis meningococcal ACWY conjugate vaccine in healthy adults aged 18-65 years. - Phase II MenB and MenACWY adult study Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member